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introduction: Surgical site infections (SSIs) and especially organ/space infection 
(O/SI) after resection or ablation of liver tumors are associated with increased morbidity 
and mortality. A secondary blood stream infection (BSI) is considered an O/SI but the 
exact prevalence is unknown. We aimed to investigate the incidence of O/SI and BSIs 
in a cohort of consecutive patients after liver resection or ablation, to seek for a possible 
connection between them and to search for potential risk factors.
Materials and methods: We reviewed all patients who underwent hepatic resection or 
intraoperative liver ablation between January 2012 and December 2016 in our depart-
ment. We focused on age, gender, Child–Pugh score, preoperative biliary drainage, indi-
cation for surgery, type of resection, resection or ablation of tumor, need for bilioenteric 
reconstruction, additional procedure to hepatectomy, blood transfusion, operative time, 
postoperative admission to ICU, and antibiotic chemoprophylaxis. All positive cultures 
from intra-abdominal fluids and blood were recorded. O/SI and BSIs were diagnosed 
by the criteria set by Centers for Disease Control. All variables were compared between 
the group with O/SI and the group without infection. BSIs were associated with these 
infections also.
results: Eighty-one consecutive patients with a mean age of 64 years were enrolled. 
Fifteen patients presented a positive culture postoperatively: intra-abdominal fluid in eight, 
blood cultures in six, and both blood and intra-abdominal fluid in one patient. The directly 
estimated incidence of O/SI amounted to 11.1%. Four blood cultures were secondary 
to O/SI, and the remaining two secondary to central line catheter. O/SI was diagnosed 
indirectly, through the BSI in an additional 4.9% of the patients, raising the incidence 
of SSI to 16%. Among the factors studied, only admission to the ICU was found to be 
statistically significant as a risk factor for the development of O/SI (p = 0.026).
Abbreviations: SSI, surgical site infection; O/SI, organ/space infection; BSI, blood stream infection; CLABSI, central line-
associated blood stream infection; CDC, Centers for Disease Control.
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inTrODUcTiOn
Postoperative infection is a common complication after liver 
resection or ablation of liver tumors. It is associated with increased 
length of stay, morbidity, and mortality (1). Despite the recent 
improvements in surgical techniques and devices, hepatectomy-
related surgical site infections (SSIs) account for about 1/3 of the 
nosocomial infections (2, 3). SSIs are classified into incisional 
(superficial and deep) and organ/space infection (O/SI), an 
important distinction due to the difference in their pathogenesis 
(4). O/SI occasionally leads to bacteremia and secondary blood 
stream infection (BSI) which in this case is also considered as SSI 
(4). We investigated the incidence of O/SI and BSI in a cohort of 
consecutive patients who underwent resection or ablation of liver 
tumors. We also seeked for a possible connection between them 
and searched for potential risk factors.
MaTerials anD MeThODs
We reviewed the medical records of all patients who underwent 
either radiofrequency-assisted liver resection or intraoperative 
radiofrequency liver ablation in our department from 2012 
till 2016. Patients’ age and gender, preoperative liver function, 
existence of preoperative biliary stent, operative data, and post-
operative need for ICU were specifically addressed. With the 
exception of a laparoscopic excisional biopsy, all other opera-
tions were open. All resections were RF-assisted according to 
the method initially described by Habib (5), and all ablations 
were conducted through radiofrequencies. The Cool-tip™ RF 
Ablation System (Medtronic Co) was employed in all operations. 
Drainage tube was placed in all patients. Enteral feeding was 
started quickly as tolerated by the patients. Antibiotic chemo-
prophylaxis was administered to all patients 1 h prior to the skin 
incision. Chemoprophylaxis scheme consisted of metronidazole 
combined with either cefoxitin or, in case of allergy to β-lactamic 
antibiotics, with ciprofloxacin. Patients with cholangitis prior 
to surgery were treated with piperacillin/tazobactam, and the 
operation was performed when all evidence of infection was 
eliminated and blood cultures became repeatedly negative. 
Patients with severe comorbidities and not ready to be extu-
bated immediately postoperatively were transferred to ICU for 
a timely extubation, in compliance with the anesthesiologists’ 
instructions. A central venous line was inserted to all patients 
immediately preoperatively and removed the first postoperative 
day or the first post-extubation day.
Primary end-points of the study were the detection of O/SI 
after liver resection or ablation and the detection of BSI second-
ary to OSI. According to the Centers for Disease Control (CDC) 
definition, diagnosis of organ/space SSI must meet the following 
criteria: the infection occurs within 30  days after the operative 
procedure if no implant is left in place or within one year if implant 
is in place and the infection appears to be related to the operative 
procedure and the infection involves any part of the anatomy (e.g., 
organs or spaces), other than the incision, opened or manipulated 
during the operative procedure. In addition, it must meet at least 
one of the following: purulent drainage from a drain that is placed 
through a stab wound into the organ/space; organisms isolated 
from an aseptically obtained culture of fluid or tissue in the organ/
space; an abscess or other evidence of infection involving the organ/
space that is found on direct examination, during reoperation, or 
by histopathologic or radiologic examination; or diagnosis of an 
organ/space SSI by a surgeon or attending physician (6).
We discriminated primary BSI from secondary-to-SSI ones 
based on the CDC definition: for a bloodstream infection to be 
determined secondary to another site of infection the following 
requirements must be met: a site-specific definition must be met; 
either one of the CDC/NHSN Surveillance Definitions for Specific 
Types of Infections, or UTI, PNEU or SSI definition AND one 
of the following scenarios must be met: Scenario 1: At least one 
organism from the blood specimen matches an organism identi-
fied from the site-specific infection that is used as an element to 
meet the NHSN site-specific infection criterion AND the blood 
specimen is collected during the secondary BSI attribution period 
(infection window period  +  repeat infection timeframe) OR 
Scenario 2: An organism identified in the blood specimen is an 
element that is used to meet the NHSN site-specific infection cri-
terion, and therefore, is collected during the site-specific infection 
window period (7).
Central line-associated blood stream infections (CLABSIs) 
were defined as laboratory-confirmed bloodstream infection 
(LCBI) where central line (CL) was in place for >2 calendar days on 
the date of event, with day of device placement being Day 1, AND 
the line was also in place on the date of event or the day before. If a 
CL was in place for >2 calendar days and then removed, the date 
of event of the LCBI must be the day of discontinuation or the next 
day to be a CLABSI (7).
Consequently, O/SIs were recorded by positive cultures from 
intra-abdominal fluids (abscess, fluids from drainage tube, etc.). 
Positive blood cultures with evidence or proof of O/SI were also 
recorded as O/SI according to the previously mentioned scenario 
2 (7). We investigated a possible correlation between these 
infectious complications and the preoperative or perioperative 
parameters.
All continuous data were expressed as the mean ± SD. Chi-
square test was used for statistical comparisons employing SPSS® 
v 22 Software.
conclusion: O/SI should be actively seeked for after liver surgery including blood 
cultures. Patients with affected physical status, comorbidities are in greater risk of devel-
oping O/SI.
Keywords: organ/space infection, radiofrequency, hepatectomy, bloodstream infections, surgical site infections, 
ablation, bacteremia
Table 4 | Type and indication of intervention leading to bilioenteric 
anastomosis, occurrence of surgical site infection.
Operation no. inf Diagnosis no. inf
Extended right hepatectomy 4 2 HCC 5 1
Right hepatectomy 4 2 Cholangiocarcinoma 10 2
Central hepatectomy 5 2 Gall bladder cancer 4 4
Left hepatectomy 4
Non-anatomic resections 2 1
Total 19 7 19 7
Table 3 | Type of liver intervention and infection occurrence.
Type of intervention no. inf
Ablation 9 2b
Anatomic resections 35 7
Bisegmentectomies 6
Left lateral 7 1
Left hepatectomy 6 1
Right hepatectomy 7 2
Central hepatectomy 5 1
Extended right hepatectomy 4 2
Metastasectomies/non-anatomic resections 37a 7
Total 81
a1 laparoscopic excisional biopsy included.
bCentral line-associated blood stream infection—blood stream infection but not surgical 
site infection (Candida, Staphylococcus).
Table 2 | indication for surgery and occurrence of positive cultures.
Diagnosis no. (+)ve culture
Liver metastasis n
Colorectal adenocarcinoma 33 4
Small bowel NET 1
Colonic NET 1
Adrenocortical carcinoma 1 1
Malignant insulinoma 1 1a
Sarcoma 1
Fallopian tube carcinoma 1
Clear cell renal cancer 1
Breast cancer 1
Cholangiocarcinoma 13 5
Gallbladder cancer 4 1
Hepatocellular carcinoma 14 2
Hepatic lymphoma 1 1a
Liver adenoma 2
Focal nodular hyperplasia 1
Liver hemangioma 1
Cholangitis 1
Hydatidosis 1
Liver cirrhosis 1
Trauma 1
Total 81 15
aCentral line-associated blood stream infection—blood stream infection but not surgical 
site infection.
Table 1 | Preoperative variables by occurrence of surgical site infection.
all 
patients 
(n = 81)
no 
postoperative 
infection 
(n = 66)
Postoperative 
infection 
(n = 15)
p Value
Mean age (years) 64 64 64.2
Gender (M/F) 48/33 37/29 11/4 0.175
Child–Pugh Score 
(A/B)
76/5 61/5 15/0 0.651
Biliary stent (yes/no) 12/69 8/58 4/11 0.151
Malignant/benign 72/9 58/6 14/1 0.472
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resUlTs
From January 2012 till December 2016, a total of 81 patients 
(48 males, 33 females) underwent either hepatic resection or 
intraoperative liver ablation in our department. As it can be seen 
in Table 1, the mean patient age was 64.07 ± 12.3 years old, no 
difference between the two sexes. Indications for liver surgery 
are listed in Table 2. Seventy-two patients (88.9%) underwent 
surgery for malignancy and 9 (11.1%) for benign tumors. 
Nine patients had liver ablation, 25 patients an anatomical 
hepatectomy, and 47 patients underwent metastasectomies or 
non-anatomical liver resection (Table 3). Metastasectomy was 
the most frequent operation (41 patients, 50.6% overall), and 
hepatic adenoma was the most common benign tumor (2.4% 
overall, 22.2% of benign tumors). No patient had a bilioenteric 
anastomosis prior to surgery; however, 12 patients had a biliary 
stent inserted preoperatively due to refractory jaundice. In 
these 12 patients and 7 additional ones, i.e., in 19 patients in 
total, bilioenteric continuity was maintained with the creation 
of a hepaticojejunostomy (Table 4). An additional concomitant 
operation, mostly a colectomy, was performed in 17 patients 
(Table  5). Seventy-six patients had a Child–Pugh score A, 5 
patients a score B, and none a score C. No patient developed 
post-hepatectomy liver failure. Perioperative characteristics by 
occurrence of SSI are depicted in Table  6. Fifty-two patients 
needed blood transfusion with a mean blood transfusion of 
2.1 units of packed red blood cells (range: 0–11, median: 1). 
With the exception of one patient suffering from lymphoma, 
all packed red blood cells used were not leukocyte depleted. 
Mean operative time for all patients was 417 ± 113 min. Sixty-
seven patients received the typical chemoprophylaxis scheme. 
Fourteen patients were treated with piperacillin/tazobactam 
preoperatively. All patients had a central venous line (mostly 
jugular) inserted immediately preoperatively. This was removed 
either the first postoperative or the first post-extubation day. 
Nineteen patients were admitted in the ICU immediately 
postoperatively for a “timely extubation” due to preexisting 
comorbidities. ICU mean length of stay was 3.37 days (ranging 
1–15 days).
Fifteen patients (11 males, 4 females) with signs of infec-
tion presented evidence of postoperative blood or organ/space 
SSI. Only intra-abdominal fluid cultures were positive in eight 
patients while blood only cultures were positive in six patients. 
One patient had both intra-abdominal fluid and blood cultures 
positive. Table  7 shows the bacteriological data of all positive 
cultures. Enterococcus sp. was isolated in seven cultures, Kebsiella 
sp. in three, E. coli in two, Pseudomonas sp. in one, and Serratia 
sp. in one. In one blood culture, both E. coli and Enterococcus were 
isolated. Two bloodstream infections could not be associated to 
SSI, one with Candida albicans and the other with Staphylococcus 
Table 5 | hepatic surgery combined with other operations and 
occurence of organ/space infections (O/si).
Type of operation no. Diagnosis O/si
Right colectomy + metastasectomies 6 5 Colonic cancer + 1 
colonic NET
Left colectomy + metastasectomies 2 Colonic cancer
Sigmoidectomy + left lateral hepatectomy 1 Colonic cancer
Sigmoidectomy + kidney 
resection + metastasectomies
1 Colonic cancer + renal 
clear cell carcinoma
Kidney resection + right hepatectomy 1 Renal clear cell 
carcinoma
Left adrenalectomy + metastasectomies 1 Adrenocortical 
carcinoma
1
Small bowel resection + metastasectomies 1 Small bowel NET
Low anterior resection + metastasectomies 3 Rectal cancer
Low anterior resection + ablation 1 Rectal cancer
Total 17
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coagulase (−) ve. In fact, these infections fulfilled the criteria for 
being characterized CLABSI and were considered as such. The 
remaining four BSIs were considered secondary to O/SI both by 
clinical and laboratory data. In conclusion, we recorded 9 patients 
with O/SI and 4 patients with BSI secondary to O/SI, i.e., 13 
patients (16%) with SSI in total. Twelve patients had an O/SI clas-
sified as Dindo II treated only with medications. The patient with 
both blood culture and intra-abdominal fluid culture positive 
was classified as Dindo IIIA because he underwent radiological 
guided drainage.
No significant difference was observed among the patients 
who developed organ/space or bloodstream infection regarding 
age, gender, Child–Pugh score, existence of preoperative biliary 
stent, or indication for surgery. Also, there was no significant 
difference in any of the perioperative parameters between the 
patients who developed a SSI and those who did not. In contrast, 
the incidence of postoperative O/SI was significantly higher in 
the patients needing ICU when compared to those hospitalized 
exclusively in the ward (36.1 vs 12.9%, p = 0.026).
DiscUssiOn
Postoperative infections continue to play a significant role in 
morbidity and mortality of surgical patients. Especially, in major 
procedures like hepatectomies, infections have a high impact on 
length of stay, total cost and can result in postoperative death (2).
We investigated the incidence of bloodstream infection and 
organ/space SSI after liver surgery and searched for associated 
risk factors. We detected an O/SI after liver resection or abla-
tion in 11.1% of our patients following the definition (6). This 
complies with the 6–10% commonly reported by others (8–10). 
An additional 4.9% of our patients were detected through a 
secondary BSI to suffer from to O/SI. In these patients, blood 
culture has been the sole microbiological data. In fact, two of 
three of our positive blood cultures had an isolated microbe 
matching O/SI. Consequently, the total true incidence of organ/
space SSI in our cohort should increase to 16% with a difference 
of approximately 50%.
This difference can be easily missed for many reasons. First 
of all, early aggressive treatment of any infection either organ/
space or bloodstream with antibiotics may cover microbiologi-
cal data and obscure further the diagnosis. Second, a correlation 
between bloodstream infection and O/SI might not have been 
attempted in every case. Finally, blood microbiological data 
are not needed for the diagnosis of O/SI, consequently blood 
cultures may not be taken routinely and data may be missing. 
O/SIs are not always verified with microbiological data and 
may be diagnosed after clinical suspicion, or signs of infection 
followed by radiological evidence only. If these are lacking the 
patient may be, temporarily, discharged from the hospital, only 
to be readmitted later on. This is supported by the findings of 
Spolverato et  al. where after 338 hepatectomies 14.2% of the 
patients were readmitted within 30  days, and 22.9% of the 
readmissions were due to intra-abdominal abscess (11). Along 
the same vein, intra-abdominal infections leading to readmis-
sion, and thus diagnosed late, represented 75% of all the intra-
abdominal infections of a cohort of 712 hepatectomies (12). In 
both series, intra-abdominal abscess was the most common 
reason for readmission.
The incidence of BSI secondary to an O/SI is not clear. About 
11% of 403 patients developed a post-hepatectomy BSI (13). This 
was considered secondary in 46% of the cases, and the source of 
infection was an intra-abdominal abscess in 28%. Furthermore, 
in 46% of the bacteremias, the onset of the infection was more 
than 2 weeks after hepatectomy. Clearly, in a number of patients 
O/SI will be diagnosed late due to the late appearance of either 
the primary infection or the secondary BSI.
Many risk factors and predictors have been implicated in the 
development of OSI. Use of silk sutures (14), postoperative bile 
leakage (3, 9, 15, 16), failure of the remnant liver (9), portal vein 
resection (1), preexisting bilioenteric anastomosis (17), and, 
interestingly, perioperative peritoneal lavage (18) have all been 
associated with increased rates of OSIs. In contrast, use of broad 
spectrum antibiotics in chemoprophylaxis (17) as cefuroxime 
alone confers no protection (19), employment of minimally 
invasive techniques (20), and avoidance of postoperative bile leak 
through the air leak test (21) seem to confer a prophylactic effect. 
Preexisting chronic liver disease and cirrhosis (22) and ERCP and 
stenting of the common bile duct (17) seem to have no effect on 
either SSI or OSI.
Perioperative blood loss, transfusion of blood or blood prod-
ucts have been reported also to have no effect on the development 
of SSI (23, 24) although others disagree (15). Our data indicate 
that blood transfusion has no effect on the development of SSI 
in liver surgery. However, we cannot draw any conclusion on the 
effect of the type of transfused blood, as described in colorectal 
surgery (25), and suggested by Okabayashi et al. (15) because only 
one of our patients received leukocyte-depleted blood.
A similar debate seems to exist regarding concomitant bowel 
surgery: it has been reported that it has no effect on the inci-
dence rates of OSI (1, 24, 26) while according to others it leads 
to increased infection rates (27). Operating on the right colon 
presents a different infective morbidity compared to colectomies 
of the hindgut (28) but evidence regarding the combination of 
liver and colorectal surgery is missing. Our results imply that 
Table 7 | association between type of positive culture and bacteria.
culture type/bacteria blood intra-
abdominal 
fluid
blood and 
intra-
abdominal 
fluid
Total
E. coli 1 1
Enterococcus 2 3 1 6
Pseudomonas 1 1
Klebsiella 3 3
Candida 1a 1
Staphylococcus 1a 1
Serratia 1 1
Mix culture: Enterococcus 
and E. coli
1 1
Total 6 8 1 15
aPositive blood cultures not associated with surgical site infection but associated with 
central line.
Table 6 | intraoperative characteristics and admission to icU by surgical site infection occurrence.
all patients (n = 81) no postoperative infection (n = 66) Postoperative infection 
(n = 15)
p Value
Type of antibiotic (simple/advanced) 67/14 57/9 10/5 0.080
Resection/ablation 72/9 59/7 13/2 0.528
aType of resection (anatomic/non-anatomic) 35/37 28/31 7/6 0.455
Constructed bilioenteric anastomosis (yes/no) 19/62 13/53 6/9 0.094
Additional procedure (yes/no) 17/64 16/50 1/14 0.119
Blood transfusion (yes/no) 52/29 41/25 11/4 0.307
Operative time (min) 417 411 444 0.320
ICU (yes/no) 19/62 12/54 7/8 0.026
aNumber of patients (n) = 72. Ablated patients were excluded.
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the addition of another procedure to hepatectomy has no effect 
on O/SI. In our cohort, neither midgut nor hindgut resections 
were followed by an infective complication. The only significant 
risk factor we were able to point out was postoperative admis-
sion to the ICU. This association may be well explained by the 
overall status of the patients. As most of the operative data 
were similar for those developing SSI and those who did not, 
postoperative need for ICU reflects the comorbidities and the 
bad performance status. Conducting a major operation to these 
fragile patients rendered them susceptible to infection, increas-
ing morbidity.
Our study has the disadvantage of being a small retrospective 
study comprising of only 81 consecutive cases of hepatectomy 
or intraoperative liver ablation. Perhaps, a greater number of 
patients would allow us to exhibit the significance of additional 
risk factors as reported in the literature. However, these are well 
described and probably we would not add anything new to the 
existing knowledge. What we aimed at was a focused investiga-
tion in O/SIs after hepatectomy, with emphasis in secondary 
bloodstream infections. We believe that true O/SIs are more 
frequent than reported because many cases are not identified 
or are identified late and not included in the published reports. 
Alternatively, they may be classified as infections of other type. 
Of course, larger studies are needed to confirm our observation 
and perhaps to identify additional risk factors. In this manner, 
we will be able to provide special care to the vulnerable patients 
being at higher risk.
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